Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
400.8 USD | -1.02% | +1.95% | -1.51% |
12:26pm | Wolfe Research Adjusts Price Target on Vertex Pharmaceuticals to $497 From $515 | MT |
Apr. 23 | Vertex Pharmaceuticals in T1D Licensing Pact With TreeFrog Therapeutics | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.51% | 104B | |
+3.22% | 97.42B | |
+1.66% | 22.2B | |
-16.53% | 21.23B | |
-9.03% | 18.33B | |
-42.33% | 16.35B | |
-20.09% | 15.06B | |
+5.47% | 13.98B | |
+28.85% | 11.66B | |
-24.93% | 8.22B |
- Stock Market
- Equities
- VRTX Stock
- News Vertex Pharmaceuticals Incorporated
- Insider Trends: Insider at Vertex Pharmaceuticals Makes Tax Sale Interrupting 90-Day Buy Trend